Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)
Clinical trial NCT01929616 · COMPLETED
Trial details
- NCT number
- NCT01929616
- Sponsor
- Jules Bordet Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-05-13
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.